Dianthus Therapeutics | MGTA - Trade Creditors



Dianthus Therapeutics reported $5.4M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Adcock Ingram Holdings 1.16B 941.66M Jun/2024
Alaunos Therapeutics USD 516K 58K Dec/2024
Avita Medical 6.29M 2.13M Dec/2024
Celltrion KRW 106.69B 31.38B Mar/2025
Cspc Pharmaceutical CNY 2.04B 548.01M Dec/2024
Dianthus Therapeutics USD 5.4M 825K Jun/2025
Divis Laboratories Ltd 9.1B 550M Mar/2025
IQVIA Holdings 3.4B 160M Jun/2025
Kangmei Pharma CNY 2.43B 2.26M Jun/2025
Laboratorios Farma EUR 57.21M 29.64M Jun/2025
Malin Corporation EUR 0 500K Dec/2024
Medical Developments International AUD 5.15M 3.11M Dec/2024
Moderna USD 175M 51M Jun/2025
Neuren Pharmaceuticals 1.45M 3.03M Dec/2024
Organigram Holdings 89.8M 26.46M Jun/2025
Organon & Co USD 1.07B 61M Jun/2025
Pharma Mar EUR 37.08M 4.92M Jun/2025
Qiagen NV USD 82.34M 12.67M Jun/2025
Revvity USD 178.15M 65K Jun/2025
Sartorius EUR 384.2M 24.6M Jun/2025
Sino Biopharmaceutical CNY 1.5B 685.94M Dec/2024
Tectonic Therapeutic USD 2.8M 1.82M Jun/2025
Tilray USD 99.08M 2.79M Nov/2024
Viatris USD 1.32B 198.2M Jun/2025
Xeris Pharmaceuticals USD 9.46M 7.17M Jun/2025
Zz Pientze Pharmaceu 484.61M 53.88M Jun/2025